Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 24, Issue 7, 2014, Pages 399-402

  Siegel, Matthew ^a,b,c   Beresford, Carol A ^d,e   Bunker, Madisun ^b   Verdi, Mary ^b   Vishnevetsky, Donna ^d   Karlsson, Cassie ^d   Teer, Olivia ^b   Stedman, Amy ^b   Smith, Kahsi A ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Spring Harbor Hospital   (United States)

^c Maine Medical Center Research Institute   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e Childrens Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM; PSYCHOTROPIC AGENT; THYROTROPIN; LITHIUM DERIVATIVE; TRANQUILIZER;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; ASPERGER SYNDROME; AUTISM; AUTOMUTILATION; CHILD; CHILD PSYCHIATRY; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DSM-IV; ENURESIS; EUPHORIA; FATIGUE; FEMALE; HUMAN; HYPERSEXUALITY; INTELLIGENCE QUOTIENT; IRRITABILITY; LITHIUM BLOOD LEVEL; MALE; MANIA; MEDICAL RECORD REVIEW; MOOD DISORDER; MOTOR RETARDATION; PARANOIA; PEDIATRICS; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; POLYDIPSIA; POLYURIA; RETROSPECTIVE STUDY; SIDE EFFECT; SLEEP DISORDER; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; TREMOR; VOMITING; BLOOD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMPLICATION; MOOD DISORDERS; PRESCHOOL CHILD; SYMPTOM ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ANTIMANIC AGENTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; MOOD DISORDERS; RETROSPECTIVE STUDIES; SYMPTOM ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907029014     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2014.0019     Document Type: Article

References (9)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Campbell M, Fish B, Korein J, Shapiro T, Collins P, Koh C: Lithium and chlorpromazine: A controlled crossover study of hyperactive severely disturbed young children. J AutismChild Schizophr 2:234-263, 1972.
3. Centers for Disease Control and Prevention: Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 61:1-19, 2012.
4. Guy W: Clinical Global Impression Scale. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: United States Department of Health, Education, and Welfare, Public Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
5. Kerbeshian J, Burd L, Fisher W: Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology. J Clin Adolesc Psychiatry 7:401-405, 1987.
6. Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J, Tager-Flusberg H, Lainhart JE: Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. J Autism Dev Disord 36:849-861, 2006.
7. Mcpheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J: A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127:e1312-1321, 2011.
8. Siegel M, Beaulieu A: Psychotropic medications in children with autism spectrum disorders: A systematic review and synthesis for evidence based practice. J Autism Dev Disord 42:1592-1605, 2012.
9. Steingard R, Biederman J: Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. J Am Acad Child Adolesc Psychiatry 26:932-935, 1987.